Drug treats hepatitis C by targeting body's RNA

03/27/2013 | Science News

A new compound drug could be effective in treating hepatitis C by attacking RNA that allows the virus to gain traction in a patient's body. The drug, miravirsen, targets the body's microRNA-122, preventing viral replication, according to findings published in the New England Journal of Medicine. The treatment could potentially also treat other serious diseases, including cancer. "This is really a revolution in science and it's now beginning to be translated into advances that control disease," said Phillip Sharp, an MIT molecular biologist who won a 1993 Nobel Prize for work on RNA.

View Full Article in:

Science News

Published in Briefs:

SmartBrief Job Listings for Education

Job Title Company Location
Learning Assessment Specialist at India's Leading K12 Education Enterprise
XSEED Education (India)
Gurgaon (New Delhi Area)
RFP Specialist, Contract Position
ASCD
Alexandria, VA
DIRECTOR OF LANGUAGE DEVELOPMENT
BOULDER VALLEY SCHOOL DISTRICT
Boulder, CO
Program Officer, Teacher Development
Knowles Science Teaching Foundation
Moorestown, NJ
DIRECTOR OF HEALTH AND CULTURE
BOULDER VALLEY SCHOOL DISTRICT
Boulder, CO